LENNARE Trademark

Trademark Overview

On Monday, June 22, 2015, a trademark application was filed for LENNARE with the United States Patent and Trademark Office. The USPTO has given the LENNARE trademark a serial number of 86670591. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 13, 2018. This trademark is owned by Amgen Inc.. The LENNARE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations used for the treatment of osteoporosis, bone disorders, bone diseases, skeletal disorders and skeletal diseases; pharmaceutical preparations used for increasing bone density, bone formation and bone growth
lennare

General Information

Serial Number86670591
Word MarkLENNARE
Filing DateMonday, June 22, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 13, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 17, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations used for the treatment of osteoporosis, bone disorders, bone diseases, skeletal disorders and skeletal diseases; pharmaceutical preparations used for increasing bone density, bone formation and bone growth

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, June 27, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Monday, August 13, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 13, 2018ABANDONMENT - NO USE STATEMENT FILED
Friday, December 22, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 20, 2017EXTENSION 3 GRANTED
Wednesday, December 20, 2017EXTENSION 3 FILED
Wednesday, December 20, 2017TEAS EXTENSION RECEIVED
Thursday, July 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 11, 2017EXTENSION 2 GRANTED
Tuesday, July 11, 2017EXTENSION 2 FILED
Tuesday, July 11, 2017TEAS EXTENSION RECEIVED
Friday, December 16, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 14, 2016EXTENSION 1 GRANTED
Wednesday, December 14, 2016EXTENSION 1 FILED
Wednesday, December 14, 2016TEAS EXTENSION RECEIVED
Tuesday, July 12, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 17, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 17, 2016PUBLISHED FOR OPPOSITION
Wednesday, April 27, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 8, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 22, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 21, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 21, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 25, 2015NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, September 25, 2015PRIORITY ACTION E-MAILED
Friday, September 25, 2015PRIORITY ACTION WRITTEN
Thursday, September 24, 2015ASSIGNED TO EXAMINER
Saturday, June 27, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 25, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

lennare bone pharmaceutical skeletal diseases disorders used preparations formation growth density